Press Release Details

Company to Offer Practitioners Point-of-Care Hemoglobin Analyzer for Fast Delivery of Blood Test Results

MELVILLE, N.Y.--(BUSINESS WIRE)--Apr. 24, 2019-- Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), announced today its new private label-branded product, OneStep™ + Pro Hb Analyzer, a portable, reagent-free hemoglobin analyzer, which measures hemoglobin concentration as a result of a fingerstick blood test. Distributed in the United States, the analyzer can quickly determine low or high levels of hemoglobin, making it possible for practitioners to determine why a patient may be fatigued or not feeling well.

“We have been working diligently to expand our private label portfolio with cost-effective, high-quality solutions our customers can rely on to meet their practice and patient needs,” said Brad Connett, President, U.S. Medical Group, Henry Schein. “With the addition of OneStep + Pro Hb Analyzer, customers at physicians’ offices, clinics and other non-traditional laboratory locations can deliver quick and convenient tests thanks to a premier analyzer with reliable, laboratory-quality performance.”

The OneStep + Pro Hb Analyzer provides clinicians at Physician Office Labs, Family/Internal Medicine clinics, OB/GYN Centers, Pediatric clinics, Planned Parenthoods, Community Health Centers and Urgent Cares with accurate hemoglobin and hematocrit measurements within three seconds of collecting a blood sample in a cuvette - a straight-sided, optically clear container for holding liquid samples - and inserting into the analyzer. This helps ensure fast results for patient health checks and anemia screening at the point-of-care setting.

For more information, please visit www.henryschein.com/onestep+prohb or call 1-800-772-4346 to speak with a Henry Schein Medical sales representative.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 18,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190424005347/en/

Source: Henry Schein, Inc.

Media: Ann Marie Gothard
Vice President, Corporate Media Relations
annmarie.gothard@henryschein.com
(631) 390-8169